Efficacy and Safety of Rituximab in Refractory CIDP With or Without IgG4 Autoantibodies (RECIPE): Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial

BACKGROUND: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune-mediated peripheral neuropathy that is currently classified into several clinical subtypes, which are presumed to have different pathogenic mechanisms. Recently, studies identified a subgroup of patients with C...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Shinobu, Iijima, Masahiro, Fukami, Yuki, Tamura, Natsuko, Nakatochi, Masahiro, Ando, Masahiko, Nishi, Ryoji, Koike, Haruki, Kaida, Kenichi, Koga, Michiaki, Kanda, Takashi, Ogata, Hidenori, Kira, Jun-Ichi, Mori, Masahiro, Kuwabara, Satoshi, Katsuno, Masahisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160709/
https://www.ncbi.nlm.nih.gov/pubmed/32234705
http://dx.doi.org/10.2196/17117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160709/
https://www.ncbi.nlm.nih.gov/pubmed/32234705
http://dx.doi.org/10.2196/17117

Ejemplares similares